Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.
Ontology highlight
ABSTRACT: Sickle cell disease is the most common hemoglobinopathy among humans. As the condition promotes susceptibility to infections, chronic inflammation, and hypercoagulability disorders, several international agencies have included individuals with this disease in the COVID-19 risk group for severe outcomes. However, available information about the subject is not properly systematized yet. This review aimed to understand and summarize the scientific knowledge about the impact of SARS-CoV-2 infection in patients with sickle cell disease. Searches were performed in the Medline, PubMed, and Virtual Health Library databases based on descriptors chosen according to the Medical Subject Headings. We analyzed studies published between 2020 and October 2022, developed with qualitative, quantitative, or
SUBMITTER: Pereira LRG
PROVIDER: S-EPMC10187638 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA